Literature DB >> 6157742

Interferon production by human and murine lymphocytes in response to alloantigens.

B Perussia, L Mangoni, H D Engers, G Trinchieri.   

Abstract

The production of interferon (IF) by human and mouse lymphocytes sensitized to alloantigens in mixed lymphocyte cultures (MLC) was analyzed. During primary MLC, IF appeared in the culture fluid on day 2 and was maximal on day 5. Based on several biologic criteria, the IF produced is of the "immune" type. When lymphocytes sensitized to alloantigens were reestimulated in vitro, IF was produced within a few hours of culture. In all stimulated cultures, cell proliferation was observed in spite of the high concentrations of IF. The IF-producing cells in human MLC were identified as T lymphocytes lacking the receptor for the Fc fragment of IgG molecules (Fc gamma R(-)). Human MLC supernatants containing immune type IF mediate the enhancement of natural killer (NK) cell activity and protect NK target cells from lysis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157742

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  HBsAg-induced interferon-gamma secretion in T cells from asymptomatic HBsAg carriers and HB-immune donors in vitro.

Authors:  S P Sylvan; U B Hellström
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

Review 2.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Human T-lymphocyte subset production of immune (gamma) interferon.

Authors:  L B Epstein; S Gupta
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

4.  Effects of activated T cells on natural killing.

Authors:  R A Knight; P Fitzharris
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

5.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

6.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

7.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

8.  Defective immune interferon production and natural killer activity associated with poor neutrophil mobility and delayed umbilical cord separation.

Authors:  E G Davies; D Isaacs; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

9.  Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy.

Authors:  S Tang; K C Le-Ruppert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

10.  Identification and expression analysis of interferon gamma genes in channel catfish.

Authors:  Ivanka Milev-Milovanovic; Scott Long; Melanie Wilson; Eva Bengten; N W Miller; V G Chinchar
Journal:  Immunogenetics       Date:  2006-02-09       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.